Bone-targeted therapies to reduce skeletal morbidity in prostate cancer. [electronic resource]
- Asian journal of andrology
- 215-220 p. digital
Publication Type: Journal Article; Review
1745-7262
10.4103/aja.aja_12_18 doi
Bone Density Conservation Agents--therapeutic use Bone Neoplasms--drug therapy Denosumab--therapeutic use Diphosphonates--therapeutic use Endothelins--antagonists & inhibitors Humans Male Prostatic Neoplasms--pathology Protein Kinase Inhibitors--therapeutic use Radioisotopes--therapeutic use Radiopharmaceuticals--therapeutic use Radium--therapeutic use Samarium--therapeutic use Strontium Radioisotopes--therapeutic use